Queen Mary University of London-ko ikertzaileekin lankidetzan egindako argitalpenak (12)

2022

  1. The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromes

    Nature Communications, Vol. 13, Núm. 1

2021

  1. A novel genetic variant in PTGS1 affects N-glycosylation of cyclooxygenase-1 causing a dominant-negative effect on platelet function and bleeding diathesis

    American Journal of Hematology

2019

  1. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

    European Journal of Immunology, Vol. 49, Núm. 10, pp. 1457-1973

2018

  1. PI3K: A crucial piece in the RAS signaling puzzle

    Cold Spring Harbor Perspectives in Medicine, Vol. 8, Núm. 6

  2. Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis

    The Lancet Haematology, Vol. 5, Núm. 8, pp. e359-e367

2017

  1. Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation

    Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

  3. RAS signalling through PI3-Kinase controls cell migration via modulation of Reelin expression

    Nature Communications, Vol. 7

  4. Tumour-suppression function of KLF12 through regulation of anoikis

    Oncogene, Vol. 35, Núm. 25, pp. 3324-3334

2011

  1. Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): A phase 3, randomised controlled trial

    The Lancet, Vol. 377, Núm. 9759, pp. 42-51

2010

  1. A transcriptional cross-talk between RhoA and c-Myc inhibits the RhoA/Rock-dependent cytoskeleton

    Oncogene, Vol. 29, Núm. 26, pp. 3781-3792